Harnessing macrophages for precision drug delivery and cancer therapy: Strategies, advances and challenges

Macrophages possess inherent tumor tropism, the capacity to traverse biological barriers, and potent immunomodulatory activity, positioning them as living carriers for precision drug delivery in cancer therapy. By leveraging these properties, macrophage-based drug delivery systems mitigate persistent limitations of conventional modalities, including poor intratumoral penetration, off-target toxicity, and rapid systemic clearance. This review highlights the unique capabilities of macrophages in drug delivery, discussing their sources, preparation, and engineering strategies for enhanced therapeutic efficacy. Key advancements in drug loading methods and applications in cancer treatment are also discussed. Despite these advancements, macrophage-based systems face challenges such as immune compatibility, large-scale production, and precise control of drug release. We conclude by outlining future opportunities to harness macrophages for precision medicine, emphasizing their transformative potential in improving cancer therapy outcomes.

Authors

Institutions

Publication Details

Journal
Materials Today Bio
Published
2025-11-08
DOI
https://doi.org/10.1016/j.mtbio.2025.102535
Citations
2
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
1.59
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Harnessing macrophages for precision drug delivery and cancer therapy: Strategies, advances and challenges

Tian Yin, Xing Tang, Jingxin Gou, Mingli Wei et al.
2 citations
Materials Today Bio
Immune cells in cancer
1.59
article

Harnessing macrophages for precision drug delivery and cancer therapy: Strategies, advances and challenges

Tian Yin, Xing Tang, Jingxin Gou, Mingli Wei, Muse Ji, Xinxin Liang, Hongbing Liu, Dongmei Shi, Yu Zhang, Haibing He
article en
2 citations

Abstract

Macrophages possess inherent tumor tropism, the capacity to traverse biological barriers, and potent immunomodulatory activity, positioning them as living carriers for precision drug delivery in cancer therapy. By leveraging these properties, macrophage-based drug delivery systems mitigate persistent limitations of conventional modalities, including poor intratumoral penetration, off-target toxicity, and rapid systemic clearance. This review highlights the unique capabilities of macrophages in drug delivery, discussing their sources, preparation, and engineering strategies for enhanced therapeutic efficacy. Key advancements in drug loading methods and applications in cancer treatment are also discussed. Despite these advancements, macrophage-based systems face challenges such as immune compatibility, large-scale production, and precise control of drug release. We conclude by outlining future opportunities to harness macrophages for precision medicine, emphasizing their transformative potential in improving cancer therapy outcomes.

Materials Today BioVol. 35
Shenyang Pharmaceutical University (CN)
Openalex Percentile: Top 14%
Immune cells in cancer
1.59
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Harnessing macrophages for precision drug delivery and cancer therapy: Strategies, advances and challenges — Tian Yin, Xing Tang, et al. · Materials Today Bio (2025) | TGRS Research Map | TGRS